Skip to main content
PRE
NASDAQ Industrial Applications And Services

Prenetics Global Raises IM8 Revenue Guidance, Reports Strong Q1 Growth & $19M Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$17.63
Mkt Cap
$295.676M
52W Low
$5.1
52W High
$23.63
52W Position info
246% above low
Off High info
25% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PRE has more than doubled off its 52-week low of $5.1.

Summary

Prenetics Global announced preliminary Q1 2026 results with strong IM8 revenue growth and raised full-year guidance, alongside the execution of a significant portion of its share buyback program.


Key Events · Earnings and Guidance · PRE

  • Raised Full-Year IM8 Revenue Guidance

    The company increased its full-year 2026 IM8 revenue guidance to $190 million-$210 million, up from the previous range of $180 million-$200 million, reflecting strong brand momentum.

  • Strong Q1 2026 Performance

    Prenetics reported preliminary Q1 2026 revenue of $36.0 million, with its IM8 brand revenue growing nearly 6x year-over-year to $33.8 million and 23.1% sequentially from Q4 2025.

  • Significant Share Repurchase Execution

    The company repurchased approximately $19 million of its Class A Ordinary Shares through May 13, 2026, representing nearly half of the authorized $40 million share buyback program.

  • Robust Cash Position

    Prenetics maintained a strong, debt-free balance sheet with approximately $147 million in combined estimated cash balances, current financial assets, and cash consideration held in escrow as of May 13, 2026.


Analysis · PRE · Industrial Applications And Services

Prenetics Global reported preliminary Q1 2026 results showing significant growth in its IM8 brand, which saw nearly 6x year-over-year revenue increase and 23.1% sequential growth. The company raised its full-year IM8 revenue guidance to $190M-$210M and executed $19 million of its share repurchase program, demonstrating strong financial health and confidence in its strategic shift to consumer health.

How filings like this one have moved

In the 30 days to Sep 13, 2026, 42% of the 419 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PRE was trading at $17.63 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $295.7M. The 52-week trading range was $5.10 to $23.63. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRE - Latest Insights

PRE
Aug 26, 2026, 8:23 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $22.17
Real-time Price: $23.52 info
Change: +$1.35 (+6%) info
Market Cap: $402.357M info
PRE
Aug 24, 2026, 9:41 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $21.82
Real-time Price: $23.52 info
Change: +$1.70 (+8%) info
Market Cap: $402.357M info
PRE
Aug 20, 2026, 10:32 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $18.76
Real-time Price: $23.52 info
Change: +$4.76 (+25%) info
Market Cap: $402.357M info
PRE
Aug 18, 2026, 7:40 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $19.99
Real-time Price: $23.52 info
Change: +$3.53 (+18%) info
Market Cap: $402.357M info
PRE
Aug 18, 2026, 7:33 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $19.45
Real-time Price: $23.52 info
Change: +$4.07 (+21%) info
Market Cap: $402.357M info